Approved Ligands

Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor.

Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor.

Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor.

Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor.

Esmolol is a short-acting hyper selective β-adrenergic blocker. It is effective in blunting adrenergic responses to several perioperative stimuli. Esmolol is effective not only in attenuating intraoperative hemodynamic changes related to sympathetic

Esmolol is a short-acting hyper selective β-adrenergic blocker. It is effective in blunting adrenergic responses to several perioperative stimuli. Esmolol is effective not only in attenuating intraoperative hemodynamic changes related to sympathetic

Esmolol is a short-acting hyper selective β-adrenergic blocker. It is effective in blunting adrenergic responses to several perioperative stimuli. Esmolol is effective not only in attenuating intraoperative hemodynamic changes related to sympathetic

Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.An immunosuppresive inhibitor of FRAP (mTOR).

Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.An immunosuppresive inhibitor of FRAP (mTOR).

Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.An immunosuppresive inhibitor of FRAP (mTOR).

Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.An immunosuppresive inhibitor of FRAP (mTOR).

Exendin-4 is an incretin mimetic peptide, which is composed of 39 amino acids. It is an analog of Glukagon-like peptide 1 (GLP-1), and an insulinotropic agent, with a long half-life. It was originally isolated from the venom of Gila monster lizard